Transcriptomic profiles of ovarian cancer cells incubated with autologous ascitic fluids from patients before and after chemotherapy
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 12 samples: 3 × cancer cells from patient 1 incubated with ascites before chemotherapy, repeat vs 3 × cancer cells from patient 1 incubated with ascites after chemotherapy, repeatGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cellsNature communications · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE241909_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1010737 and SRA study SRP457546. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 6 samples.
How we read this: 2 replicated groups read from 12 sample titles; they account for 6 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7745504 cancer cells from patient 3 incubated with ascites before chemotherapy
- GSM7745505 cancer cells from patient 3 incubated with ascites after chemotherapy
- GSM7745506 cancer cells from patient 6 incubated with ascites before chemotherapy
- GSM7745507 cancer cells from patient 6 incubated with ascites after chemotherapy
- GSM7745508 cancer cells from patient 11 incubated with ascites before chemotherapy
- GSM7745509 cancer cells from patient 11 incubated with ascites after chemotherapy
- GSM7745510 cancer cells from patient 1 incubated with ascites before chemotherapy, repeat 1 cancer cells from patie…
- GSM7745511 cancer cells from patient 1 incubated with ascites after chemotherapy, repeat 1 cancer cells from patie…
- GSM7745512 cancer cells from patient 1 incubated with ascites before chemotherapy, repeat 2 cancer cells from patie…
- GSM7745513 cancer cells from patient 1 incubated with ascites after chemotherapy, repeat 2 cancer cells from patie…
- GSM7745514 cancer cells from patient 1 incubated with ascites before chemotherapy, repeat 3 cancer cells from patie…
- GSM7745515 cancer cells from patient 1 incubated with ascites after chemotherapy, repeat 3 cancer cells from patie…
- GSE241908 Transcriptomic profiles of ovarian cancer cells isolated from paired cancer ascites before and after chemotherapy 14 samples shares chemotherapy, profiles, ovarian
- GSE232352 Lifetime ovulatory years and ovarian cancer gene expression profiles 234 samples shares profiles, ovarian
- GSE222556 Neoadjuvant PARPi or Chemotherapy in Ovarian Cancer Informs Targeting Effector Treg Cells for Homologous-Recombination-Deficient Tumors [10x scRNA-seq] 67 samples shares chemotherapy, ovarian
- GSE266577 Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer 48 samples shares chemotherapy, ovarian
- GSE224392 Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human) 21 samples shares chemotherapy, ovarian
- GSE269793 Neoadjuvant PARPi or Chemotherapy in Ovarian Cancer Informs Targeting Effector Treg Cells for Homologous-Recombination-Deficient Tumors [Singleron scRNA-seq] 10 samples shares chemotherapy, ovarian
- GSE222557 Neoadjuvant PARPi or Chemotherapy in Ovarian Cancer Informs Targeting Effector Treg Cells for Homologous-Recombination-Deficient Tumors 148 samples shares chemotherapy, ovarian
- GSE284400 Gene expression and mutation profiles in advanced-stage epithelial ovarian cancer (EOC) 78 samples shares profiles, ovarian
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.